S A Kuznetsova
Overview
Explore the profile of S A Kuznetsova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Averina O, Kuznetsova S, Permyakov O, Sergiev P
Mol Biol (Mosk)
. 2024 Dec;
58(4):525-548.
PMID: 39709560
The CRISPR/Cas technology of targeted genome editing made it possible to carry out genetic engineering manipulations with eukaryotic genomes with a high efficiency. Targeted induction of site-specific DNA breaks is...
2.
Averina O, Kuznetsova S, Permyakov O, Sergiev P
Mol Biol (Mosk)
. 2024 Dec;
58(4):508-524.
PMID: 39709559
Modern genetic engineering technologies, such as base editing and prime editing (PE), have proven to provide the efficient and reliable genome editing tools that obviate the need for donor templates...
3.
Drozd N, Kuznetsova S, Skurydina E, Vasilieva N, Levdansky V
Bull Exp Biol Med
. 2024 Sep;
177(5):621-625.
PMID: 39347869
The hemocompatibility of arabinogalactan, betulin and its derivatives was evaluated in vitro and samples suitable for creation of nanostructures or materials in contact with blood were selected. The prospects of...
4.
Averina O, Kuznetsova S, Permyakov O, Sergiev P
Acta Naturae
. 2024 Jan;
15(4):4-22.
PMID: 38234606
Mitochondrial diseases (MDs) associated with nuclear gene mutations are part of a large group of inherited diseases caused by the suppression of energy metabolism. These diseases are of particular interest,...
5.
Drozd N, Kuznetsova S, Malyar Y, Kazachenko A
Bull Exp Biol Med
. 2022 May;
173(1):98-104.
PMID: 35622245
We identified compounds that do not independently provoke aggregation of human platelets and do not affect hemolysis of human erythrocytes in vitro: lacking anticoagulant activity sulfated galactoglucomannan (polydispersity 1.43; degree...
6.
Drozd N, Kuznetsova S, Malyar Y, Vasilyeva N, Kuznetsov B
Bull Exp Biol Med
. 2020 Oct;
169(6):815-820.
PMID: 33123918
The effects of sulfated organosolv lignins derived from fir (Abies sibirica) and larch (Larix sibirica) (SLf and SLl; 4-3-7.5% sulfur, median-weight molecular mass 2960-4888 Da), on human blood/plasma clotting, platelet...
7.
Kuznetsova S, Petrukov K, Pletnev F, Sergiev P, Dontsova O
Biochemistry (Mosc)
. 2019 Sep;
84(8):851-869.
PMID: 31522668
The review summarizes the data on pro- and eukaryotic RNA (C5-cytosine) methyltransferases. The structure, intracellular location, RNA targets, and catalytic mechanisms of these enzymes, as well as the functional role...
8.
Parovichnikova E, Loukianova I, Troitskaya V, Drokov M, Lobaova T, Kuzmina L, et al.
Ter Arkh
. 2019 Feb;
90(7):14-22.
PMID: 30701918
Aim: To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials And Methods: Inductive and...
9.
Drozd N, Kuznetsova S, Levdansky V, Mikhailenko M
Bull Exp Biol Med
. 2017 Nov;
164(2):158-161.
PMID: 29185171
Sulfated derivatives of xylan (isolated from Bétula pubéscens wood) with average molecular weight ~34 kDa, sulfur content of 11.3-17.5%, a degree of substitution of 0.74-1.64 are anticoagulants of direct type...
10.
Starkov A, Zamay T, Savchenko A, Ingevatkin E, Titova N, Kolovskaya O, et al.
Dokl Biochem Biophys
. 2016 May;
467(1):92-4.
PMID: 27193706
The article presents the results of investigation of antitumor properties of platinum-arabinogalactan complex. We showed the ability of the complex to inhibit the growth of Ehrlich ascites tumor cells. It...